Topical Tofacitinib for Atopic Dermatitis – Outcomes from Randomized Phase 3 Clinical Trial: First Approval.
Saved in:
| Title: | Topical Tofacitinib for Atopic Dermatitis – Outcomes from Randomized Phase 3 Clinical Trial: First Approval. |
|---|---|
| Authors: | Chaturvedi, Alok R.1 (AUTHOR), Zaveri, Hemant G.1 (AUTHOR) hemant_zaveri@intaspharma.com, Patel, Dhaval V.1 (AUTHOR) |
| Source: | Indian Journal of Dermatology. Jan/Feb2026, Vol. 71 Issue 1, p44-50. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
